Gennaro Ciliberto

Istituti Fisioterapici Ospitalieri — Italy

Medicine · Health Sciences

86h-index34.3kcitations784works1.92yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Cancer Immunotherapy and Biomarkers(106), Immunotherapy and Immune Responses(89), Virus-based gene therapy research(60), Cancer Genomics and Diagnostics(59), Lung Cancer Treatments and Mutations(55)

Publications778 total

Additional file 1 of PROTAC-mediated degradation of Bcl-xL potentiates target therapy in preclinical melanoma models
Figshare·2026Open Access
Additional file 2 of PROTAC-mediated degradation of Bcl-xL potentiates target therapy in preclinical melanoma models
Figshare·2026Open Access
Additional file 2 of PROTAC-mediated degradation of Bcl-xL potentiates target therapy in preclinical melanoma models
Figshare·2026Open Access
Additional file 1 of PROTAC-mediated degradation of Bcl-xL potentiates target therapy in preclinical melanoma models
Figshare·2026Open Access
miRquad: first-in-class dPCR multiplex TaqMan™ Advanced clinical research assay for microRNA detection in head and neck cancer
Journal of Experimental & Clinical Cancer Research·2025Open Access
Integrated screening for small molecules interfering with PKM2: a drug repurposing strategy against glioblastoma
Journal of Translational Medicine·2025Open Access
An Extract, Transform, Load foundation for Biobank Data Interoperability
Journal of Data and Information Quality·2025· 1 citedOpen Access
Novel Humanized Anti-HER3 Antibodies: Structural Characterization and Therapeutic Activity
Antibodies·2025Open Access
miRquad: first-in-class dPCR multiplex TaqMan™ Advanced RUO assay for microRNA detection in head and neck cancer
2025Open Access
1721P External validation of Rachel score: A prognostic tool for lung neuroendocrine tumors (conclusive insights)
Annals of Oncology·2025
Development of an innovative duplex digital PCR assay for circulating MiRNA ratio quantification in metastatic melanoma
Journal of Translational Medicine·2025· 2 citedOpen Access
Association between neoadjuvant paclitaxel dose intensity and outcomes in early triple-negative and HER2-positive breast cancer: a real-world data analysis
ESMO Real World Data and Digital Oncology·2025· 1 citedOpen Access
Development of a unified system for assessing health related quality of life across the cancer care continuum: the EUonQoL Delphi study to identify priorities for quality of life domains
Journal of Patient-Reported Outcomes·2025· 2 citedOpen Access
Metabolic Reprogramming in Melanoma: An Epigenetic Point of View
Pharmaceuticals·2025· 6 citedOpen Access
Fostering the implementation of liquid biopsy in clinical practice: meeting report 2024 of the European Liquid Biopsy Society (ELBS)
Journal of Experimental & Clinical Cancer Research·2025· 9 citedOpen Access
Implementation of a Digital Maturity Framework for Biobanking
Journal of Biomedical Informatics·2025· 1 citedOpen Access
Evaluating the Involvement of People With Cancer and Informal Caregivers in the Development Process of a New Set of Quality of Life Questionnaires
Health Expectations·2025Open Access
Abstract 3372: Building precision oncology via real-world data standardization, privacy preserving infrastructures, and collaboration among IT and clinical experts: The DIGICORE network experience
Cancer Research·2025· 1 cited
A decalogue of Molecular Tumor Board (MTB) recommendations from the CAN.HEAL Consortium
European Journal of Cancer·2025· 1 citedOpen Access
Repurposing Existing Drugs for Glioblastoma therapy: A Metabolic-Based Screening Strategy
2025Open Access
page 1 of 39Next →

Frequent Co-authors

Elena Fattori(7), Paolo A. Ascierto(6), Valeria Poli(6), Carlo Toniatti(6), R. Cortese(6), Gerardo Botti(5), Rebecca Taub(5), Domenico Lazzaro(5), Riccardo Cortese(5), Giuseppe Masucci(4), Francesco M. Marincola(4), Bernard A. Fox(4), Rocco Savino(4), Diana Giannarelli(4), Nicola La Monica(4), Franck Pagès(3), Carlo Bifulco(3), Tilman T. Rau(3), Jérôme Galon(3), Linda E. Greenbaum(3)